Skip to content
Omecamtiv mecarbil
Omecamtiv mecarbil is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
15 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Heart failureD006333EFO_0003144I5028313
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Left ventricular dysfunctionD01848711
Stroke volumeD01331811
PharmacokineticsD01059911
Myocardial ischemiaD017202EFO_1001375I20-I2511
Angina pectorisD000787EFO_0003913I2011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients11
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOMECAMTIV MECARBIL
INNomecamtiv mecarbil
Description
Omecamtiv mecarbil is a member of ureas.
Classification
Small molecule
Drug classcardiac myosin activator
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1
Identifiers
PDB
CAS-ID873697-71-3
RxCUI
ChEMBL IDCHEMBL1800955
ChEBI ID
PubChem CID11689883
DrugBankDB11816
UNII ID2M19539ERK (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 622 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
6,951 adverse events reported
View more details